Claire Patterson

487 total citations
8 papers, 270 citations indexed

About

Claire Patterson is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Claire Patterson has authored 8 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Claire Patterson's work include Chemical Synthesis and Analysis (2 papers), Computational Drug Discovery Methods (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Claire Patterson is often cited by papers focused on Chemical Synthesis and Analysis (2 papers), Computational Drug Discovery Methods (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Claire Patterson collaborates with scholars based in United Kingdom, Singapore and United States. Claire Patterson's co-authors include Manuel Sánchez-Félix, Hunter H. Chen, Sachin Mittal, Paul A. Dickinson, Richard A. Barker, Wendy Burke, L. J. Ashworth, Mohammed Yasin, Philip H. Kass and Jill A. Nord and has published in prestigious journals such as Advanced Drug Delivery Reviews, International Journal of Pharmaceutics and Pharmaceutical Research.

In The Last Decade

Claire Patterson

8 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Claire Patterson United Kingdom 6 98 91 42 32 29 8 270
Xiaofang Wang China 13 118 1.2× 36 0.4× 27 0.6× 47 1.5× 41 1.4× 40 453
Blisse Vakkalagadda United States 10 103 1.1× 67 0.7× 10 0.2× 38 1.2× 79 2.7× 14 379
Hugh Schieren United States 12 191 1.9× 37 0.4× 17 0.4× 30 0.9× 10 0.3× 23 460
Jack B. Cohen United States 12 98 1.0× 70 0.8× 7 0.2× 33 1.0× 52 1.8× 31 494
Qiuping Ma China 8 122 1.2× 32 0.4× 19 0.5× 12 0.4× 77 2.7× 20 410
Belén Valenzuela Spain 14 133 1.4× 20 0.2× 14 0.3× 45 1.4× 189 6.5× 43 440
Paul A. Kramer United States 7 131 1.3× 113 1.2× 19 0.5× 7 0.2× 40 1.4× 11 422
John Garner United States 8 80 0.8× 118 1.3× 13 0.3× 17 0.5× 34 1.2× 10 354
Andreas Mahl Switzerland 6 74 0.8× 12 0.1× 10 0.2× 43 1.3× 36 1.2× 9 397

Countries citing papers authored by Claire Patterson

Since Specialization
Citations

This map shows the geographic impact of Claire Patterson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Claire Patterson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Claire Patterson more than expected).

Fields of papers citing papers by Claire Patterson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Claire Patterson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Claire Patterson. The network helps show where Claire Patterson may publish in the future.

Co-authorship network of co-authors of Claire Patterson

This figure shows the co-authorship network connecting the top 25 collaborators of Claire Patterson. A scholar is included among the top collaborators of Claire Patterson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Claire Patterson. Claire Patterson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Forbes, Ben, Lynne Goodacre, Alison B. Lansley, et al.. (2025). Advances in Nasal Biopharmaceutics to Support Product Development and Therapeutic Needs. Pharmaceutics. 17(10). 1321–1321. 1 indexed citations
2.
Sonzini, Silvia, Fanny Caputo, Dóra Méhn, et al.. (2023). In depth characterization of physicochemical critical quality attributes of a clinical drug-dendrimer conjugate. International Journal of Pharmaceutics. 637. 122905–122905. 7 indexed citations
3.
Gajjar, Parmesh, et al.. (2022). Determining bioequivalence possibilities of long acting injectables through population PK modelling. European Journal of Pharmaceutical Sciences. 179. 106296–106296. 9 indexed citations
4.
Sánchez-Félix, Manuel, et al.. (2020). Predicting bioavailability of monoclonal antibodies after subcutaneous administration: Open innovation challenge. Advanced Drug Delivery Reviews. 167. 66–77. 114 indexed citations
5.
6.
Buss, Nicholas, Patricia C. Ryan, Todd M. Baughman, et al.. (2018). Nonclinical safety and pharmacokinetics of Miglyol 812: A medium chain triglyceride in exenatide once weekly suspension. Journal of Applied Toxicology. 38(10). 1293–1301. 14 indexed citations
7.
8.
Karter, Andrew J., Robert Yarrish, Claire Patterson, et al.. (1995). Vitamin A deficiency in non-vitamin-supplemented patients with AIDS: a cross-sectional study.. PubMed. 8(2). 199–203. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026